Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib
The signaling pathway of miR29B-mediated apoptosis involves the degradation of EZH2 and the inhibition of BTK. Ibrutinib effectively inhibits and inactivates BTK, a critical component of the B-cell receptor signaling (BCR) pathway. On the other hand, MS1943 acts as a potent EZH2 degrader. Simultaneous induction of these reactions leads to the upregulation of miR29B, which in turn activates the downstream pathway involving TP53. The increased levels of TP53 promote the expression of PUMA, a pro-apoptotic protein, ultimately leading to cell death. The activation of PUMA induces mitochondrial dysfunction through a series of intricate processes. Subsequently, caspase-3 is activated and cleaved, triggering the cleavage of PARP within the cell nucleus. This cascade of events ultimately culminates in apoptosis. It is worth noting that XIAP, an anti-apoptotic protein, inhibits the activity of cleaved caspase-3.
Publication
Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib. (2023) Yurim Jeong, et al. Front Oncol. 2023;13:1252658. Figure: F7.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | BCR | BCR | ncbigene_symbol | BCR | 613 |
| Homo sapiens | Primates | BCR | BCR | ncbigene_synonym | RN7SL263P | 106480993 |
| Homo sapiens | Primates | BTK | BTK | ncbigene_symbol | BTK | 695 |
| Homo sapiens | Primates | (EZH2) | EZH2 | ncbigene_symbol | EZH2 | 2146 |
| Homo sapiens | Primates | TP53 | TP53 | ncbigene_symbol | TP53 | 7157 |
| Homo sapiens | Primates | miR29B↑→→ | MIR29B | ncbigene_synonym | MIR29B1 | 407024 |
| Homo sapiens | Primates | PARP | PARP | ncbigene_synonym | PARP1 | 142 |
| Homo sapiens | Primates | PARP | PARP | ncbigene_synonym | COL11A2 | 1302 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP2 | 10038 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP3 | 10039 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP4 | 143 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP6 | 56965 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP8 | 79668 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP9 | 83666 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP10 | 84875 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP11 | 57097 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP12 | 64761 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP14 | 54625 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP15 | 165631 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP16 | 54956 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | TNKS | 8658 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | TNKS2 | 80351 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | TIPARP | 25976 |
| Homo sapiens | Primates | PUMA | PUMA | ncbigene_synonym | BBC3 | 27113 |
| Homo sapiens | Primates | XIAP | XIAP | ncbigene_symbol | XIAP | 331 |
| Danio rerio | Vertebrates | BCR | BCR | ncbigene_symbol | bcr | 568320 |
| Danio rerio | Vertebrates | BTK | BTK | ncbigene_symbol | btk | 568653 |
| Danio rerio | Vertebrates | (EZH2) | EZH2 | ncbigene_symbol | ezh2 | 768133 |
| Danio rerio | Vertebrates | TP53 | TP53 | ncbigene_symbol | tp53 | 30590 |
| Danio rerio | Vertebrates | PARP | PARP | ncbigene_synonym | parp14rs2.1 | 101885419 |
| Danio rerio | Vertebrates | XIAP | XIAP | ncbigene_symbol | xiap | 373108 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|